Goodwin advised BridgeBio Pharma on the matter.BridgeBio Pharma, Inc. (Nasdaq: BBIO) and Kyowa Kirin Co., Ltd (TSE:4151) announced a partnership wherein BridgeBio’s affiliate, QED Therapeutics, grants…
BridgeBio Pharma’s Partnership with Kyowa Kirin
![](https://globallegalchronicle.com/wp-content/uploads/2024/02/bridgebio-pharmas-partnership-with-kyowa-kirin_65d8369c9a299-480x360.jpeg)